Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2 		0.030 Biomarker group LHGDN Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. 15014021 2004
Entrez Id: 25890
Gene Symbol: ABI3BP
ABI3BP 		0.010 AlteredExpression group LHGDN Cancer-associated loss of TARSH gene expression in human primary lung cancer. 16205947 2006
Entrez Id: 25
Gene Symbol: ABL1
ABL1 		0.030 AlteredExpression group LHGDN Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells. 16410245 2006
Entrez Id: 25
Gene Symbol: ABL1
ABL1 		0.030 GeneticVariation group BEFREE Furthermore, we confirm that imatinib suppresses lung tumor growth in vivo, specifically in lung cancer cells harboring a gain-of-function (GOF) mutation in ABL1. 26758680 2016
Entrez Id: 25
Gene Symbol: ABL1
ABL1 		0.030 AlteredExpression group LHGDN Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1. 17486070 2007
Entrez Id: 1636
Gene Symbol: ACE
ACE 		0.310 GeneticVariation group LHGDN Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. 18156303 2008
Entrez Id: 1636
Gene Symbol: ACE
ACE 		0.310 Biomarker group CTD_human Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis. 21552421 2011
Entrez Id: 43
Gene Symbol: ACHE
ACHE 		0.020 AlteredExpression group BEFREE High levels of Acetylcholinesterase (AChE) activity have been reported in primary brain tumors, ovarian, colon and lung tumors. 29623856 2018
Entrez Id: 43
Gene Symbol: ACHE
ACHE 		0.020 AlteredExpression group LHGDN Acetylcholinesterase biogenesis is impaired in lung cancer tissues. 16429485 2005
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3 		0.040 Biomarker group BEFREE CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. 17898181 2007
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3 		0.040 Biomarker group BEFREE Carcinogen-induced lung tumor incidence was similar in IP(+/+), IP(+/-), and IP(-/-) mice, and overexpression of PGIS gave equal protection in all three groups, indicating that the protective effects of prostacyclin are not mediated through activation of IP. 19138979 2008
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3 		0.040 GeneticVariation group BEFREE Previously, we found that mice with a knockout (KO) of G-protein coupled receptor 5A (Gprc5a) develop lung tumors after a long latent period (12 to 24 months). 20686609 2010
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3 		0.040 GeneticVariation group BEFREE Earlier work revealed that mice with knockout of the G-protein coupled receptor Gprc5a develop late onset lung tumors including LUADs. 28653505 2017
Entrez Id: 47
Gene Symbol: ACLY
ACLY 		0.010 Biomarker group LHGDN ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. 18922930 2008
Entrez Id: 116285
Gene Symbol: ACSM1
ACSM1 		0.300 Biomarker group CTD_human A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays. 17114358 2007
Entrez Id: 60
Gene Symbol: ACTB
ACTB 		0.310 Biomarker group CTD_human Proteomic analysis of differentially expressed proteins in lung cancer in Wistar rats using NNK as an inducer. 23692979 2013
Entrez Id: 60
Gene Symbol: ACTB
ACTB 		0.310 AlteredExpression group BEFREE Afterwards, a panel of eight genes known to be expressed in lung tumors was used for the detection of tumor-associated mRNA expression in lavage supernatant and serum. mRNA coding for beta-actin could be isolated from lavage supernatant of all 25 patients. 15251953 2004
Entrez Id: 100
Gene Symbol: ADA
ADA 		0.300 Biomarker group CTD_human [Increase of the functional activity of natural killers under the effects of the pharmacological correction of the sympathoadrenal system state in patients with lung cancer]. 2305558 1990
Entrez Id: 8038
Gene Symbol: ADAM12
ADAM12 		0.010 AlteredExpression group LHGDN Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). 16495931 2006
Entrez Id: 10863
Gene Symbol: ADAM28
ADAM28 		0.300 Biomarker group CTD_human ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas. 20544843 2010
Entrez Id: 101
Gene Symbol: ADAM8
ADAM8 		0.010 AlteredExpression group LHGDN ADAM8 as a novel serological and histochemical marker for lung cancer. 15623614 2004
Entrez Id: 8754
Gene Symbol: ADAM9
ADAM9 		0.030 AlteredExpression group BEFREE ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis. 26553452 2015
Entrez Id: 8754
Gene Symbol: ADAM9
ADAM9 		0.030 AlteredExpression group LHGDN Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. 15205330 2004
Entrez Id: 8754
Gene Symbol: ADAM9
ADAM9 		0.030 AlteredExpression group BEFREE Moreover, ADAM9 levels in brain metastases derived from lung tumors were relatively higher than the levels observed in primary lung tumors. 25060522 2014
Entrez Id: 9510
Gene Symbol: ADAMTS1
ADAMTS1 		0.020 AlteredExpression group LHGDN Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). 16495931 2006